Authored By: Sarah
11 Jul 2024

 Glycobiology Market Size to grow by USD 2219.9 million between 2024-2028

According to a research report “ Glycobiology Market” by Application (Drug discovery and development, Disease diagnostics, Others) Product (Enzymes, Instruments, Reagents, Kits) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 2219.9 million, at a CAGR of  18.52% during the forecast period. In the global health landscape, cancer continues to pose a significant challenge due to its prevalence and impact as the second leading cause of death. This chronic condition is characterized by the uncontrolled growth of cells, with major contributing factors being genetic mutations, environmental elements such as tobacco smoking and pollution, and shifting dietary trends. The importance of glycobiology in cancer research has emerged due to the crucial role of surface glycans in the metastatic and neoplastic properties of tumor cells. Consequently, the application of glycobiology in pharmaceutical research and development, as well as the production of therapeutic monoclonal antibodies, is anticipated to fuel market growth throughout the forecast period.

Browse market data tables, figures, and in-depth TOC on “Glycobiology Market” by Application (Drug discovery and development, Disease diagnostics, Others) Product (Enzymes, Instruments, Reagents, Kits) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample


By Application, the Drug discovery and development segment is projected to dominate the market size in 2024

In the realm of glycobiology, enzymes hold a pivotal position. Transferases facilitate the intricate synthesis of carbohydrates, while glycosidases and sulfatases are instrumental in their metabolism and structural modification. These enzymes serve as indispensable tools for deciphering carbohydrate structures and functions. They enable the identification and elucidation of oligosaccharide structures of interest and the manipulation of carbohydrate structures to discern their impact on biological functions. The burgeoning field of drug discovery and development is anticipated to fuel the expansion of the enzymes segment within the global glycobiology market over the forecast period.

By Product, Enzymes  segment is expected to hold the largest market size for the year 2024

In the realm of biotechnology, glycobiology holds significant importance due to its role in drug discovery and development. Glycans, a subset of carbohydrates, are integral to numerous biological processes. They can manifest as basic monosaccharides or intricate structures, such as naturally occurring complex carbohydrates, where the sugar moiety is tethered to a protein or lipid. Carbohydrates serve various critical functions, including acting as the most abundant molecule in the body, providing energy through glucose metabolism, and contributing to the structural integrity of cell walls. Complex glycans are essential for proper folding of newly synthesized polypeptides, ensuring final stability, solubility, and transport of glycoproteins. Furthermore, carbohydrates are ubiquitous on cell surfaces, mediating essential biological functions through the specific recognition of glycan structures by other biomolecules.

North America is forecasted to hold the largest market size by region in 2024

The glycobiology market represents a significant and growing business sector, driven by the increasing recognition of the role of glycans in various biological processes and their potential as therapeutic targets. Companies are investing heavily in research and development to expand their glycobiology product portfolios, leveraging advanced technologies to produce innovative solutions for diagnostics, therapeutics, and industrial applications. This market is poised for robust growth due to its wide-ranging impact across multiple industries.

The Glycobiology Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Agilent Technologies Inc.
  • Asparia Glycomics
  • Bio Techne Corp.
  • Bruker Corp.
  • CD BioGlyco
  • Chemily Glycoscience
  • Genovis AB
  • ICE S.p.a.
  • Lectenz Bio
  • Ludger Ltd.
  • Merck KGaA
  • New England Biolabs Inc.
  • NZYTech
  • Plexera LLC
  • Shimadzu Corp.
  • Sumitomo Bakelite Co. Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corp.
  • ZBiotech

For insights on company offerings- Request a sample report!

Research Analysis Overview

Glycobiology, the study of carbohydrates and their roles in living organisms, is a rapidly growing field with significant implications for various industries, particularly pharmaceutical and biotechnology. Glycomics research efforts have led to valuable learnings from proteomics examinations, revealing the importance of glycans in protein function and cellular communication. Pharmaceutical and biotechnology firms, administration groups, and academic institutions are increasing their analysis spending on glycobiology, driven by the potential for new drug discoveries and therapeutic applications. Technologies such as Capillary Electrophoresis (CE), Mass Spectrometry (MS), and High-Performance Liquid Chromatography (HPLC) are essential tools in this field, enabling the analysis of glycosides, glycosidase inhibitors, polysaccharides, lectin inhibitors, anti-glycan antibodies, glycan antigens, glycan-binding proteins, and glycans themselves. Key players in the glycobiology market include Agilent Technologies, which offers glycan analysis solutions using CE and MS technologies. The market is expected to grow significantly due to the increasing demand for glycobiology-related products and services in various industries. As the field continues to evolve, the potential applications of glycobiology in drug discovery, diagnostics, and biotechnology are vast and promising.

Market Research Overview

The glycobiology market is experiencing significant growth due to the increasing focus on biomolecular therapeutics, drug delivery systems, vaccine development, and antiviral therapeutics. The market is driven by the diagnosis and treatment of chronic diseases such as obesity and diabetes, which require a deeper understanding of the complex carbohydrate structures, or glycans, that play crucial roles in these conditions. The proteomics sector, including pharmaceutical and biotechnology firms, administration groups, and Contract Research Organizations (CROs), are investing heavily in glycomics research efforts to advance molecular diagnosis, oncology, immunology, and nanomedicine. Technologies such as Capillary Electrophoresis (CE), Mass Spectrometry (MS), and High-Performance Liquid Chromatography (HPLC) are being utilized for glycomics analysis. Hydroxychloroquine, a treatment drug used for various diseases, is an example of a glycoside that has been studied extensively. The development of glycan nanostructures, glycosaminoglycans like hyaluronan, and glycosides, glycosidase inhibitors, polysaccharides, lectin inhibitors, anti-glycan antibodies, and glycan antigens are all areas of active research in the glycobiology market. The diagnostic industry and health-care spending are major factors driving the growth of the glycobiology market. The market is expected to continue expanding as pharmaceutical and biotechnology firms increase their investment in glycomics research and development, leading to new treatments, diagnostics, and drug delivery systems.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!